QTNT News and Press, Quotient Limited From 11/08/21

Executive Leadership Team: Recent new hires will support anticipated rapid growth and help lead future development MosaiQ™ Solution Transfusion Dx: The Expanded Immunohematology CE regulatory dossier has been submitted with 20 specificities; and Expanded Serolog...

Quotient (NASDAQ:QTNT) is scheduled to announce Q2 earnings results on Tuesday, November 9th, before market open. The consensus EPS Estimate is -$0.28 (-55.6% Y/Y) and the consensus Revenue Estimate is $8.56M (-46.7% Y/Y). For further details see: Quotient Q2 2022 Earnings Preview

ADT,AGEN,AGTC,ALLT,APRN,AUD,OTCPK:BAYZF,BHVN,BNTX,BSY,CAH,CANO,CCO,CEVA,CNCE,CORR,DCTH,DHI,DRNA,EBIX,ECOM,EGRX,EPZM,EXK,FOLD,GILT,GLNG,GOL,HAE,HAIN,HGV,HUYA,IGT,IIVI,INSW,ISEE,ITCI,KNDI,KPLT,MIDD,MLCO,MNTV,MRNS,MRSN,MSGE,OTCPK:NSANY,NSPR,NUWE,OCGN,OESX,OSG,OWL,PLTR,PRPL,PRTY,QTNT,SATS,SEAS,SE...

JERSEY, Channel Islands, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that financial results for its fiscal second quarter ended September 30, 2021 will be released before market open on Tuesday, ...

Notes holders unanimously consent to amendments Company’s near-term cash obligations reduced by approximately $60 million Transaction extends liquidity runway through commercial launch and provides resources for further MosaiQ investment JERSEY, Channe...

Gainers: Homology Medicines (NASDAQ:FIXX) +6%. Chimerix (NASDAQ:CMRX) +5%. Vimeo (NASDAQ:VMEO) +5%. View (NASDAQ:VIEW) +4%. SMART Global Holdings (NASDAQ:SGH) +4%. Losers: Neuronetics (NASDAQ:STIM) -22%. Quotient Limited (NASDAQ:QTNT) -9%. CRISPR Therapeutics (NASDAQ:CRSP) -8%. Sare...

JERSEY, Channel Islands, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Company’s Chief Financial Officer (CFO). Mr. Kiboro will assume the responsibilities of CFO on November 1 st , 202...

JERSEY, Channel Islands, Oct. 05, 2021 (GLOBE NEWSWIRE) --  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced Mohammad El Khoury as the Company’s Chief Commercial Officer. In this role, Mr. El Khoury will oversee all commercial activities fo...

JERSEY, Channel Islands, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Dr. Christine Ginocchio as Chief Scientific & Medical Officer (CSMO). “We are delighted to welcome Dr. Ginocch...

Shares of Quotient Limited (NASDAQ: QTNT) rose as high as 21% on Friday. The stock hits its 52-week low on Thursday at $2.32 per share before closing at $2.34. On Friday, it opened at $2.35 before climbing to as high as $2.85 in midday training. The stock has been volatile, climbing...